Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Soft Tissue Neoplasms × binimetinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Neoplasm Metastasis 3 Lung Neoplasms 2 Gastrointestinal Stromal Tumors 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Solid Tumor 1 Soft Tissue Neoplasms 1 Recurrence 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02285439 2025-10-07

Study of MEK162 for Children With Low-Grade Gliomas

Children's Hospital Los Angeles

Phase 1/2 Completed

105 enrolled 17 charts

Brain Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡